Dersalazine Free Base
Dersalazine is a platelet-activating factor inhibitor that demonstrates intestinal anti-inflammatory effects in rodent colitis models, primarily through down-regulation of IL-17. This mechanism supports its research potential for ulcerative colitis, with applications in both in vivo pharmacological studies and in vitro pathway analysis.
Product Specifications
CAS Number
188913-58-8
Product Name Alternative
Plateletaggregation, Platelet aggregation, platelet-activating factor (PAF), IL Receptor, ILReceptor, IL-17A, Dersalazine, Dersalazine Free Base
Field of Research
Immunology & Inflammation, Pharmacology & Drug Discovery
Purity
98.00% (May vary between batches)
Solubility
DMSO:< 1 mg/mL (insoluble or slightly soluble) ; H2O:< 1 mg/mL (insoluble or slightly soluble)
Smiles
C (N1C=2C (N=C1C) =CN=CC2) C3CCN (C (/C=C (\C4=CC=C (N=NC5=CC (C (O) =O) =C (O) C=C5) C=C4) /C6=CC=CC=C6) =O) CC3
Molecular Formula
C35H32N6O4
Molecular Weight
600.67
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
HIRA (HIR Histone Cell Cycle Regulation Defective Homolog A (S. cerevisiae), HIR, DGCR1, Protein HIRA, TUP1-like Enhancer of Split Protein 1, TUP1, TUPLE1) (PE)
HIRA (HIR Histone Cell Cycle Regulation Defective Homolog A (S. cerevisiae), HIR, DGCR1, Protein HIRA, TUP1-like Enhancer of Split Protein 1, TUP1, TUPLE1) (PE)
